{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:03:36Z","timestamp":1789607016972,"version":"build-2803163510"},"reference-count":45,"publisher":"CSIRO Publishing","issue":"5","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,20]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Men who have sex with men (MSM) are a key population with a higher prevalence of hepatitis C virus (HCV) infection than the general population. Our study estimated the prevalence of current HCV infection and identified risk factors among MSM aged 20\u201359\u00a0years in the US from 1999 to 2016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were obtained from the 1999\u20132016 National Health and Nutrition Examination Survey (NHANES). Current HCV infection was defined as having a positive HCV RNA test result. The prevalence of current HCV infection was weighted according to the complex survey design of NHANES. A Rao\u2013Scott Chi-squared test was used to compare the differences between HCV-positive and HCV-negative MSM. Multivariable logistic regression was used to identify risk factors for current HCV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the US, nearly 5.1% (95% CI 4.5\u20135.7) of the general population self-reported as MSM. The weighted prevalence of current HCV infection was 1.8% (95% CI 1.5\u20132.1) among non-institutionalized US males, and 3.5% (95% CI 1.9\u20135.7) among MSM. Current HCV infection among MSM was associated with injection drug use (aOR 29.2, 95% CI 12.1\u201370.8), blood transfusion (aOR 8.2, 95% CI 1.5\u201345.7), being aged 40\u201359\u00a0years (aOR 4.0, 95% CI 1.6\u201310.1) and having a poverty income ratio &amp;lt;1.0 (aOR 5.8, 95% CI 1.3\u201325.2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the US, the prevalence of current HCV infection is nearly twice as high among MSM as among males in the general population, suggesting the need for surveillance of the HCV epidemic among MSM. Prevention and control strategies targeting the risk factors are critical to combating the HCV epidemic among MSM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh26054","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:46:52Z","timestamp":1787802412000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factors of current hepatitis C infection among men who have sex with men aged 20\u201359 years: NHANES 1999\u20132016"],"prefix":"10.1071","volume":"23","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[{"name":"ADepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewei","family":"Liu","sequence":"additional","affiliation":[{"name":"BDepartment of AIDS Control and Prevention, Guangzhou Baiyun District Center for Disease Control and Prevention, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Lin","sequence":"additional","affiliation":[{"name":"ADepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agins","family":"Bruce","sequence":"additional","affiliation":[{"name":"CHEALTHQUAL, Division of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California, San Francisco, CA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"She","sequence":"additional","affiliation":[{"name":"DDepartment of Stomatology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China."},{"name":"EGuangzhou (Huangpu) Zhongliu Biomedical Innovation Center, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-4460","authenticated-orcid":true,"given":"Hongbo","family":"Jiang","sequence":"additional","affiliation":[{"name":"ADepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026091620065592000_R1"},{"issue":"8","key":"2026091620065592000_R2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"2026091620065592000_R3","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1053\/j.gastro.2009.07.047","article-title":"Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.","volume":"137","author":"Kim","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"2026091620065592000_R4","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with Hepatitis C virus in the United States, 2003\u20132013.","volume":"62","author":"Ly","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026091620065592000_R5","unstructured":"Centers for Disease Control and Prevention. 2021 viral hepatitis surveillance report; 2024. Available at https:\/\/www.cdc.gov\/hepatitis-surveillance-2021\/about\/index.html [accessed 21 October 2025]"},{"issue":"10","key":"2026091620065592000_R6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/ciad411","article-title":"Estimated prevalence and awareness of hepatitis C virus infection among US adults: national health and nutrition examination survey, January 2017-March 2020.","volume":"77","author":"Lewis","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2026091620065592000_R7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41575-022-00608-8","article-title":"Breakthroughs in hepatitis C research: from discovery to cure.","volume":"19","author":"Manns","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091620065592000_R8","unstructured":"Global health sector strategy on viral hepatitis 2016\u20132021. World Health Organization; 2016. Available at https:\/\/iris.who.int\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf [accessed 21 October 2025]"},{"key":"2026091620065592000_R9","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on a National Strategy for the Elimination of Hepatitis B and C. A national strategy for the elimination of hepatitis B and C: phase two report. (Eds BL Strom, GJ Buckley). Washington (DC): National Academies Press (US); 2017."},{"issue":"4","key":"2026091620065592000_R10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.livres.2022.12.003","article-title":"Prevalence, diagnosis, treatment, and associated factors of hepatitis C in the United States from 1999 to 2018: a population-based cross-sectional study.","volume":"6","author":"Zhang","year":"2022","journal-title":"Liver Res"},{"issue":"26","key":"2026091620065592000_R11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.15585\/mmwr.mm7226a3","article-title":"Hepatitis C virus clearance cascade - United States, 2013-2022.","volume":"72","author":"Wester","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2026091620065592000_R12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination \u2013 a path to global elimination of hepatitis C.","volume":"67","author":"Lazarus","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"2026091620065592000_R13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S2468-1253(20)30303-4","article-title":"Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis.","volume":"6","author":"Jin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"2026091620065592000_R14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"2026091620065592000_R15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S2468-1253(20)30358-7","article-title":"Hepatitis C among men who have sex with men: knowing your epidemic.","volume":"6","author":"Rauch","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"2026091620065592000_R16","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jhep.2016.07.012","article-title":"HCV epidemiology in high-risk groups and the risk of reinfection.","volume":"65","author":"Midgard","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"2026091620065592000_R17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/QCO.0b013e32835c2120","article-title":"Sexually transmitted hepatitis C infection: the new epidemic in MSM?","volume":"26","author":"Bradshaw","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2026091620065592000_R18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.","volume":"62","author":"AASLD\/IDSA HCV Guidance Panel","year":"2015","journal-title":"Hepatology"},{"issue":"10","key":"2026091620065592000_R19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 Update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.","volume":"67","author":"AASLD-IDSA HCV Guidance Panel","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2026091620065592000_R20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad401","article-title":"Incidence and prevalence of hepatitis C virus among HIV-negative gay and bisexual men using HIV pre-exposure prophylaxis (PrEP): a systematic review and meta-analysis.","volume":"10","author":"Traeger","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"2026091620065592000_R21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cgh.2021.03.006","article-title":"Incidence of hepatitis C virus infections among users of human immunodeficiency virus pre-exposure prophylaxis.","volume":"20","author":"Tabatabavakili","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2026091620065592000_R22","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/cid\/ciae297","article-title":"Hepatitis C virus reinfection among men who have sex with men with HIV in New York City.","volume":"79","author":"Fierer","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2026091620065592000_R23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/OLQ.0000000000000762","article-title":"Men who have sex with men-identification criteria and characteristics from the national health and nutrition examination survey, 1999 to 2014.","volume":"45","author":"Esie","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"5","key":"2026091620065592000_R24","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/infdis\/jiab224","article-title":"Trends in prevalence and characteristics of resolved and current hepatitis B among US-born persons: national health and nutrition examination survey, 2001-2018.","volume":"224","author":"Ly","year":"2021","journal-title":"J Infect Dis"},{"issue":"12","key":"2026091620065592000_R25","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/cid\/ciz669","article-title":"Prevalence of hepatitis B virus infection among US adults aged 20-59 years with a history of injection drug use: national health and nutrition examination survey, 2001-2016.","volume":"70","author":"Shing","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2026091620065592000_R26","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/hep.27367","article-title":"Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.","volume":"60","author":"Xiao","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"2026091620065592000_R27","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03536-3","article-title":"The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999-2018.","volume":"22","author":"Yu","year":"2024","journal-title":"BMC Med"},{"issue":"2","key":"2026091620065592000_R28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.12691\/ajams-8-2-1","article-title":"Detecting multicollinearity in regression analysis.","volume":"8","author":"Shrestha","year":"2020","journal-title":"Am J Appl Math Stat"},{"issue":"2","key":"2026091620065592000_R29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/ajpas\/2019\/v5i230132","article-title":"Diagnosing multicollinearity of logistic regression model.","volume":"5","author":"Senaviratna","year":"2019","journal-title":"Asian J Probab Stat"},{"issue":"2","key":"2026091620065592000_R30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults - United States, 2020.","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"18","key":"2026091620065592000_R31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.15585\/mmwr.mm6618a2","article-title":"State HCV incidence and policies related to HCV preventive and treatment services for persons who inject drugs - United States, 2015-2016.","volume":"66","author":"Campbell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2026091620065592000_R32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jhep.2015.06.014","article-title":"Excluding people who use drugs or alcohol from access to hepatitis C treatments \u2013 Is this fair, given the available data?","volume":"63","author":"Grebely","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"2026091620065592000_R33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2105\/AJPH.2017.303748","article-title":"Restrictions of hepatitis C treatment for substance-using medicaid patients: cost versus ethics.","volume":"107","author":"Liao","year":"2017","journal-title":"Am J Public Health"},{"key":"2026091620065592000_R34","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103247","article-title":"Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: a knowledge synthesis.","volume":"96","author":"Amoako","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"6","key":"2026091620065592000_R35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/infdis\/jiad169","article-title":"Impact of HCV testing and treatment on HCV transmission among men who have sex with men and who inject drugs in San Francisco: a modelling analysis.","volume":"228","author":"Artenie","year":"2023","journal-title":"J Infect Dis"},{"issue":"6","key":"2026091620065592000_R36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jvh.12866","article-title":"Assessing hepatitis C spontaneous clearance and understanding associated factors \u2013 a systematic review and meta-analysis.","volume":"25","author":"Aisyah","year":"2018","journal-title":"J Viral Hepat"},{"issue":"4","key":"2026091620065592000_R37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jhep.2013.11.014","article-title":"The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.","volume":"60","author":"Ditah","year":"2014","journal-title":"J Hepatol"},{"issue":"10","key":"2026091620065592000_R38","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/apt.18242","article-title":"Trends of chronic liver diseases by income level and socioeconomic factors in the United States: a population-based study.","volume":"60","author":"Lee","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2026091620065592000_R39","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.amepre.2017.01.033","article-title":"Recent hepatitis C virus testing patterns among baby boomers.","volume":"53","author":"Jemal","year":"2017","journal-title":"Am J Prev Med"},{"issue":"5","key":"2026091620065592000_R40","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26251","article-title":"Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling study.","volume":"27","author":"Wu","year":"2024","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2026091620065592000_R41","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02981-w","article-title":"Expanding hepatitis C virus test uptake using self-testing among men who have sex with men in China: two parallel randomized controlled trials.","volume":"21","author":"Wang","year":"2023","journal-title":"BMC Med"},{"issue":"1","key":"2026091620065592000_R42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/QCO.0000000000000020","article-title":"Eradicating syphilis, hepatitis C and HIV in MSM through frequent testing strategies.","volume":"27","author":"Fairley","year":"2014","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"2026091620065592000_R43","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1016\/S2352-3018(22)00128-X","article-title":"Engaging with HCV reinfection to advance microelimination.","volume":"9","author":"Garvey","year":"2022","journal-title":"Lancet HIV"},{"issue":"5","key":"2026091620065592000_R44","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review.","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"issue":"3","key":"2026091620065592000_R45","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25461","article-title":"National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.","volume":"23","author":"Sullivan","year":"2020","journal-title":"J Int AIDS Soc"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH26054\/1949857\/sh26054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH26054\/1949857\/sh26054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:07:04Z","timestamp":1789603624000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/23\/5\/SH26054\/275726\/Prevalence-and-risk-factors-of-current-hepatitis-C"}},"subtitle":[],"editor":[{"given":"Matthew","family":"Hogben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10,20]]}},"URL":"https:\/\/doi.org\/10.1071\/sh26054","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"SH26054"}}